Javascript must be enabled to continue!
Morocco’s First Biobank: Establishment, Ethical Issues, Biomedical Research Opportunities, and Challenges
View through CrossRef
Background. Biobanks are highly organized infrastructures that allow the storage of human biological specimens associated with donors’ personal and clinical data. These infrastructures play a key role in the development of translational medical research. In this context, we launched, in November 2015, the first biobank in Morocco (BRO Biobank) in order to promote biomedical research and provide opportunities to include Moroccan and North African ethnic groups in international biomedical studies. Here, we present the setup and the sample characteristics of BRO Biobank. Methods. Patients were recruited at several departments of two major health‐care centers in the city of Oujda. Healthy donors were enrolled during blood donation campaigns all over Eastern Morocco. From each participant, personal, clinical, and biomedical data were collected, and several biospecimens were stored. Standard operating procedures have been established in accordance with international guidelines on human biobanks. Results. Between November 2015 and July 2020, 2446 participants were recruited into the BRO Biobank, of whom 2013 were healthy donors, and 433 were patients. For healthy donors, the median age was 35 years with a range between 18 and 65 years and the consanguinity rate was 28.96%. For patients, the median age was 11 years with a range between 1 day and 83 years. Among these patients, 55% had rare diseases (hemoglobinopathies, intellectual disabilities, disorders of sex differentiation, myopathies, etc.), 13% had lung cancer, 4% suffered from hematological neoplasms, 3% were from the kidney transplantation project, and 25% had unknown diagnoses. The BRO Biobank has collected 5092 biospecimens, including blood, white blood cells, plasma, serum, urine, frozen tissue, FFPE tissue, and nucleic acids. A sample quality control has been implemented and suggested that samples of the BRO Biobank are of high quality and therefore suitable for high‐throughput nucleic acid analysis. Conclusions. The BRO Biobank is the largest sample collection in Morocco, and it is ready to provide samples to national and international research projects. Therefore, the BRO Biobank is a valuable resource for advancing translational medical research.
Wiley
Saida Lhousni
Karam Yahya Belmokhtar
Ihab Belmokhtar
Mounia Elidrissi Errahhali
Manal Elidrissi Errahhali
Redouane Boulouiz
Mariam Tajir
Majida Charif
Khawla Zerrouki
Noufissa Benajiba
Maria Rkain
Abdeladim Babakhouya
Hatim Kouismi
Afaf Thouil
Hanane Latrach
Rim Amrani
Sahar Messaoudi
Anass Ayyad
Zaina Sidqi
Khalid Andaloussi Serraj
Siham Hamaz
Habiba Alaoui
Houda Bachir
Yassamine Bentata
Intissar Haddiya
Mohammed Choukri
Rachid Seddik
Amal Bennani
Siham Dikhaye
Bouchra Oneib
Fatima Elghazouani
Omar El Mahi
Adnane Benzirar
Ayat Allah Oufkir
Brahim Housni
Ahmed Mimouni
Hanane Saadi
Mohammed Belahcen
Tijani El Harroudi
Meryem Ouarzane
Mohammed Bellaoui
Title: Morocco’s First Biobank: Establishment, Ethical Issues, Biomedical Research Opportunities, and Challenges
Description:
Background.
Biobanks are highly organized infrastructures that allow the storage of human biological specimens associated with donors’ personal and clinical data.
These infrastructures play a key role in the development of translational medical research.
In this context, we launched, in November 2015, the first biobank in Morocco (BRO Biobank) in order to promote biomedical research and provide opportunities to include Moroccan and North African ethnic groups in international biomedical studies.
Here, we present the setup and the sample characteristics of BRO Biobank.
Methods.
Patients were recruited at several departments of two major health‐care centers in the city of Oujda.
Healthy donors were enrolled during blood donation campaigns all over Eastern Morocco.
From each participant, personal, clinical, and biomedical data were collected, and several biospecimens were stored.
Standard operating procedures have been established in accordance with international guidelines on human biobanks.
Results.
Between November 2015 and July 2020, 2446 participants were recruited into the BRO Biobank, of whom 2013 were healthy donors, and 433 were patients.
For healthy donors, the median age was 35 years with a range between 18 and 65 years and the consanguinity rate was 28.
96%.
For patients, the median age was 11 years with a range between 1 day and 83 years.
Among these patients, 55% had rare diseases (hemoglobinopathies, intellectual disabilities, disorders of sex differentiation, myopathies, etc.
), 13% had lung cancer, 4% suffered from hematological neoplasms, 3% were from the kidney transplantation project, and 25% had unknown diagnoses.
The BRO Biobank has collected 5092 biospecimens, including blood, white blood cells, plasma, serum, urine, frozen tissue, FFPE tissue, and nucleic acids.
A sample quality control has been implemented and suggested that samples of the BRO Biobank are of high quality and therefore suitable for high‐throughput nucleic acid analysis.
Conclusions.
The BRO Biobank is the largest sample collection in Morocco, and it is ready to provide samples to national and international research projects.
Therefore, the BRO Biobank is a valuable resource for advancing translational medical research.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
AbstractPurposeLong-term humoral immunity to COVID-19 is not well understood owing to the continuous emergence of new variants of concern, the evolving vaccine- and infection-induc...
Materialism and Environmental Knowledge as a Mediator for Relationships between Religiosity and Ethical Consumption
Materialism and Environmental Knowledge as a Mediator for Relationships between Religiosity and Ethical Consumption
ABSTRACTOn a global and regional scale, Indonesia has one of the least environmentally sustainable economies in the Asia-Pacific region. Consumption is one of the key factors contr...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Phanerozoic Vertical Movements in Morocco
Phanerozoic Vertical Movements in Morocco
Our understanding of the Earth’s interior is limited by the access we have of its deep layers, while the knowledge we have of Earth’s evolution is restricted to harvested informati...
A Critique of Principlism
A Critique of Principlism
Photo by Towfiqu barbhuiya on Unsplash
INTRODUCTION
Bioethics does not have an explicitly stated and agreed upon means of resolving conflicts between normative theories. As such, b...

